Tumor necrosis factor α attenuates interferon‐α signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy
- 9 May 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (9), 1595-1597
- https://doi.org/10.1096/fj.00-0908fje
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Importance of Kupffer Cells for T-Cell-Dependent Liver Injury in MiceThe American Journal of Pathology, 2000
- IL‐10 attenuates IFN‐α‐activated STAT1 in the liver: involvement of SOCS2 and SOCS3FEBS Letters, 2000
- Signaling pathways activated by interferonsExperimental Hematology, 1999
- Serum and liver concentrations of tumor necrosis factor α and interleukin-1β following administration of carbon tetrachloride to male ratsToxicology Letters, 1998
- Expression of Cytokine mRNA in Extrahepatic Organs in a Mouse Concanavalin A-Hepatitis ModelThe Japanese Journal of Pharmacology, 1998
- Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral DiseaseCell, 1996
- Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling PathwayCell, 1996
- Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis CHepatology, 1996
- Phenotypical analysis and cytokine release of liver‐infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiologyLiver International, 1994
- Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infectionJournal of Hepatology, 1991